Ramón Gomis-rekin lankidetzan egindako argitalpenak (2)

2017

  1. Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

    International Journal of General Medicine, Vol. 10, pp. 23-26

2011

  1. Vildagliptina

    Permanyer